Johnson Pharmacare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2026 ,inter alia, to consider and approve To consider and approve ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Johnson Pharmacare Ltd has informed BSE that a Board meeting is scheduled for 27th May 2026 to consider and approve the Audited Financial Results for the quarter and year ended 31st March 2026. The company has also closed its Trading Window from 1st April 2026, which will remain shut until 48 hours after the results declaration. This is a standard prior intimation filing under SEBI LODR Regulations. No financial details or preliminary numbers are disclosed in this notice. The meeting will be held at the company's registered office in Ahmedabad.
This is a routine board meeting notice; no immediate impact on shareholders until actual financial results are disclosed. Investors should note the trading window closure and await the official results announcement expected after 27th May 2026.